ATG5 and hepatocellular carcinoma: Western blotting analysis results demonstrated that pre-treatment of HCC cells with TUDCA effectively reversed increase of the expression levels of LC3B-II, Beclin1, and Atg5 and decrease of the expression level of p62/SQSTM1 (p<0.01) (Fig. 5b).